<?xml version="1.0" encoding="UTF-8"?>
<p>In a COVID-19 laboratory diagnosis, serological tests use enzyme-linked immunosorbent assay (ELISA) or Western blotting that detects specific SARS-CoV-2 proteins, while molecular approaches are based on RT-PCR or Northern blot hybridization targeting specific SARS-CoV-2 genes (
 <xref rid="B25" ref-type="bibr">25</xref>). Direct immunofluorescence assay (IFA) is used to detect viral antigens present in the specimen, whereas the total lymphocyte count (TLC) and chest CT examination can also be used in SARS-CoV-2 infections (
 <xref rid="B23" ref-type="bibr">23</xref>). Some diagnostic features along with the treatment targets are depicted in 
 <xref ref-type="fig" rid="F3">Figure 3</xref>.
</p>
